Pharmacokinetics and Metabolism Study in Healthy Male Participants

Completed · Phase 1

Conditions studied: Cancer

In brief

Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males

Key facts

Study ID

NCT03247283

Run by

Bristol-Myers Squibb

People needed

9

Starts

2017-07-19

Expected to finish

2017-10-15

Last updated by the study team

2017-11-06

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Body weight 75-95kg, BMI 18.0-32.0 kg/m\^2
• Refrain from sperm donation 110 days after dosing

You may not qualify if…

• Current or recent gastrointestinal disease
• Any GI surgery that could impact drug absorption
• Active, known, or suspected autoimmune disease
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• Covance Clinical Research Unit, Inc. — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.